FindTrial
Sign In

GENETICS IN HEART ATTACK

GENETIC STUDY OF CHEMOKINE RECEPTOR GENE(CCR5) POLYMORPHISM IN ACUTE CORONARY SYNDROME IN VIJAYAPURA POPULATION.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032889
Enrollment
80
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

DrPRASHANTH MR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted with ST segment elevation, non-ST segment elevation myocardial infarction and unstable angina.

Exclusion criteria

Exclusion criteria: 1.Patient diagnosed with Diabetes mellitus. 2.valvular heart disease.

Design outcomes

Primary

MeasureTime frame
TO IDENTIFY THE INDIVIDUAL WITH CHEMOKINE RECEPTOR GENE (CCR5) DELTA 32 BASE PAIR DELETION IN PATIENT OF ACUTE CORONARY SYNDROMETimepoint: 14 months—

Secondary

MeasureTime frame
UTILIZING THE STUDY AS GROUND DATA FOR SCREENING GENERAL POPULATION WHO ARE AT RISK OF ACUTE CORONARY SYNDROME AND EARLY INTERVENTION WILL REDUCE THE BURDEN OF DISEASE IN TERMS OF MORTALITY AND MORBIDITYTimepoint: 6 months from the date of study is completed—

Countries

India

Contacts

Public ContactBADIGER SHARANABASAWAPPA

B.L.D.E(DEEMED TO BE UNIVERSITY)SHRI B.M.PATIL MEDICAL COLLEGE AND RESEARCH CENTRE

sharanrb@rediffmail.com9448434927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026